Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $14.5 million.

  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) rose 0.07% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.5 million, marking a year-over-year increase of 0.07%. This contributed to the annual value of $14.5 million for FY2024, which is 8.18% up from last year.
  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) amounted to $14.5 million in Q3 2025, which was up 0.07% from $14.5 million recorded in Q2 2025.
  • Inhibrx Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $14.5 million for Q3 2025, and its period low was $13.4 million during Q4 2023.
  • In the last 3 years, Inhibrx Biosciences' Shares Outstanding (Weighted Average) had a median value of $14.5 million in 2025 and averaged $14.1 million.
  • Data for Inhibrx Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY rose of 8.18% (in 2024) over the last 5 years.
  • Inhibrx Biosciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $13.4 million in 2023, then grew by 8.18% to $14.5 million in 2024, then rose by 0.07% to $14.5 million in 2025.
  • Its last three reported values are $14.5 million in Q3 2025, $14.5 million for Q2 2025, and $14.5 million during Q1 2025.